Hospital Acquired Infections Market is expected to grow at a CAGR of 6.13% during the forecast period. Global Hospital Acquired Infections Market is expected to reach US$ 35.02 Bn. by 2029.To know about the Research Methodology :- Request Free Sample Report
Hospital Acquired infections Market Dynamics
Hospital acquired infections (HAIs) are also referred to as nosocomial infections. In this kind of infections, the patient acquires additional diseases while receiving cure for surgical or medical conditions. HAIs are probable in all settings of care, including surgical centres, hospitals, long-term care facilities such as rehabilitation facilities and nursing homes, and ambulatory clinics. HAIs are more prevalent in developing countries. Certain factors that are driving the market growth include the increase in hospital stay due to chronic diseases and surgeries, rise in the incidences of different types of hospital-acquired infections. Additionally, factor like rise in geriatric population base coupled with demand for hospital-acquired infection diagnostics from middle and low-income economies.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. However, factors such as increased microbial resistance, counterfeit and spurious products, off label usage of drugs and antiseptics, increased application of glass and ceramics in building materials, extensive market fragmentation, tough competition, penetration of generics, and loss of patent, are acting as significant restraints to the market growth. Hospital acquired infections market is segmented by infection type, method of treatment, and pathogen types. By pathogen types, the market is segmented into bacterial, fungal, and viral. Based on treatment method, the market has been segmented into Sterilants, Disinfectants and other products. Based on infection type, the market has been segmented into bloodstream infections, urinary tract infections, gastrointestinal infections, respiratory infections, and surgical site infections.Hospital Acquired infections Market Regional Insights
By geography, Hospital acquired infection is segmented into Europe, North America, APAC, Middle East & Africa, and Latin America. North America is the largest regional segment of the global hospital acquired infection control market. Moreover, the APAC and Latin American regions are expected to witness significant growth over the forecast period. Primarily due to rising incidences of HAIs, growing number of hospitals, increasing medical tourism in emerging countries such as China and India, rising aging population with the resultant increase in the number of chronic disease cases. The hospital acquired infection market is dominated by major players such as Becton, Dickinson and company, Advanced Sterilization Products, Belimed AG, Getinge AB, Cantel Medical Corp., STERIS Corporation, 3M Company, and others. The objective of the report is to present comprehensive analysis of Hospital Acquired Infections Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Hospital Acquired Infections Market dynamics, structure by analysing the market segments, and project the global critical communication market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Hospital Acquired Infections Market make the report investor’s guide.Hospital Acquired Infections Market Scope: Inquire before buying
Global Hospital Acquired Infections Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 23.09 Bn. Forecast Period 2023 to 2029 CAGR: 6.13% Market Size in 2029: US $ 35.02 Bn. Segments Covered: by Pathogen Types Viral Bacterial Fungal by Method of Treatment Sterilization Chemical Radiation by Infection Type Urinary Tract Infections Blood Stream Infections Surgical Site Infections Gastrointestinal Infections Respiratory Infections Hospital Acquired Infections Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Hospital Acquired Infections Market Key players
1. Becton 2. Dickinson and Company (U.S.) 3. Steris Corporation (U.S.) 4. Advanced Sterilization Products 5. Getinge Group (Sweden) 6. Kimberly-Clark Corporation (U.S.) 7. Cantel Medical (U.S.) 8. BioMérieux SA (France) 9. Belimed AG (Switzerland) 10.3M Company (U.S.) 11.Sterigenics International LLC. (U.S.) 12.Synergy Health, plc (U.K.) 13.Abbott 14.Astra Zeneca 15.Bayer AG 16.Pfizer Inc. 17.GlaxoSmithKline plc 18.Johnson and Johnson Services, Inc. 19.Merck and Co., Inc. 20.Cipla Inc. 21.Eli Lilly and Company 22.Bristol-Myers Squibb Company 23.F. Hoffmann-La Roche Ltd. Frequently Asked Questions: 1. Which region has the largest share in Global Hospital Acquired Infections Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Hospital Acquired Infections Market? Ans: The Global Market is growing at a CAGR of 6.13% during forecasting period 2023-2029. 3. What is scope of the Global market report? Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global market? Ans: The important key players in the Global Market are – Becton, Dickinson and Company (U.S.), Steris Corporation (U.S.), Advanced Sterilization Products, Getinge Group (Sweden), Kimberly-Clark Corporation (U.S.), Cantel Medical (U.S.), BioMérieux SA (France), Belimed AG (Switzerland), 3M Company (U.S.), Sterigenics International LLC. (U.S.), Synergy Health, plc (U.K.), Abbott, Astra Zeneca, Bayer AG, Pfizer Inc., GlaxoSmithKline plc, Johnson and Johnson Services, Inc., Merck and Co., Inc., Cipla Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., and 5. What is the study period of this market? Ans: The Global Market is studied from 2022 to 2029.
1. Hospital Acquired Infections Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Hospital Acquired Infections Market: Dynamics 2.1. Hospital Acquired Infections Market Trends by Region 2.1.1. North America Hospital Acquired Infections Market Trends 2.1.2. Europe Hospital Acquired Infections Market Trends 2.1.3. Asia Pacific Hospital Acquired Infections Market Trends 2.1.4. Middle East and Africa Hospital Acquired Infections Market Trends 2.1.5. South America Hospital Acquired Infections Market Trends 2.2. Hospital Acquired Infections Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Hospital Acquired Infections Market Drivers 2.2.1.2. North America Hospital Acquired Infections Market Restraints 2.2.1.3. North America Hospital Acquired Infections Market Opportunities 2.2.1.4. North America Hospital Acquired Infections Market Challenges 2.2.2. Europe 2.2.2.1. Europe Hospital Acquired Infections Market Drivers 2.2.2.2. Europe Hospital Acquired Infections Market Restraints 2.2.2.3. Europe Hospital Acquired Infections Market Opportunities 2.2.2.4. Europe Hospital Acquired Infections Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Hospital Acquired Infections Market Drivers 2.2.3.2. Asia Pacific Hospital Acquired Infections Market Restraints 2.2.3.3. Asia Pacific Hospital Acquired Infections Market Opportunities 2.2.3.4. Asia Pacific Hospital Acquired Infections Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Hospital Acquired Infections Market Drivers 2.2.4.2. Middle East and Africa Hospital Acquired Infections Market Restraints 2.2.4.3. Middle East and Africa Hospital Acquired Infections Market Opportunities 2.2.4.4. Middle East and Africa Hospital Acquired Infections Market Challenges 2.2.5. South America 2.2.5.1. South America Hospital Acquired Infections Market Drivers 2.2.5.2. South America Hospital Acquired Infections Market Restraints 2.2.5.3. South America Hospital Acquired Infections Market Opportunities 2.2.5.4. South America Hospital Acquired Infections Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Hospital Acquired Infections Industry 2.8. Analysis of Government Schemes and Initiatives For Hospital Acquired Infections Industry 2.9. Hospital Acquired Infections Market Trade Analysis 2.10. The Global Pandemic Impact on Hospital Acquired Infections Market 3. Hospital Acquired Infections Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 3.1.1. Viral 3.1.2. Bacterial 3.1.3. Fungal 3.2. Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 3.2.1. Sterilization 3.2.2. Chemical 3.2.3. Radiation 3.3. Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 3.3.1. Urinary Tract Infections 3.3.2. Blood Stream Infections 3.3.3. Surgical Site Infections 3.3.4. Gastrointestinal Infections 3.3.5. Respiratory Infections 3.4. Hospital Acquired Infections Market Size and Forecast, by Region (2022-2029) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Hospital Acquired Infections Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 4.1.1. Viral 4.1.2. Bacterial 4.1.3. Fungal 4.2. North America Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 4.2.1. Sterilization 4.2.2. Chemical 4.2.3. Radiation 4.3. North America Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 4.3.1. Urinary Tract Infections 4.3.2. Blood Stream Infections 4.3.3. Surgical Site Infections 4.3.4. Gastrointestinal Infections 4.3.5. Respiratory Infections 4.4. North America Hospital Acquired Infections Market Size and Forecast, by Country (2022-2029) 4.4.1. United States 4.4.1.1. United States Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 4.4.1.1.1. Viral 4.4.1.1.2. Bacterial 4.4.1.1.3. Fungal 4.4.1.2. United States Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 4.4.1.2.1. Sterilization 4.4.1.2.2. Chemical 4.4.1.2.3. Radiation 4.4.1.3. United States Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 4.4.1.3.1. Urinary Tract Infections 4.4.1.3.2. Blood Stream Infections 4.4.1.3.3. Surgical Site Infections 4.4.1.3.4. Gastrointestinal Infections 4.4.1.3.5. Respiratory Infections 4.4.2. Canada 4.4.2.1. Canada Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 4.4.2.1.1. Viral 4.4.2.1.2. Bacterial 4.4.2.1.3. Fungal 4.4.2.2. Canada Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 4.4.2.2.1. Sterilization 4.4.2.2.2. Chemical 4.4.2.2.3. Radiation 4.4.2.3. Canada Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 4.4.2.3.1. Urinary Tract Infections 4.4.2.3.2. Blood Stream Infections 4.4.2.3.3. Surgical Site Infections 4.4.2.3.4. Gastrointestinal Infections 4.4.2.3.5. Respiratory Infections 4.4.3. Mexico 4.4.3.1. Mexico Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 4.4.3.1.1. Viral 4.4.3.1.2. Bacterial 4.4.3.1.3. Fungal 4.4.3.2. Mexico Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 4.4.3.2.1. Sterilization 4.4.3.2.2. Chemical 4.4.3.2.3. Radiation 4.4.3.3. Mexico Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 4.4.3.3.1. Urinary Tract Infections 4.4.3.3.2. Blood Stream Infections 4.4.3.3.3. Surgical Site Infections 4.4.3.3.4. Gastrointestinal Infections 4.4.3.3.5. Respiratory Infections 5. Europe Hospital Acquired Infections Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 5.2. Europe Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 5.3. Europe Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 5.4. Europe Hospital Acquired Infections Market Size and Forecast, by Country (2022-2029) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 5.4.1.2. United Kingdom Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 5.4.1.3. United Kingdom Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 5.4.2. France 5.4.2.1. France Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 5.4.2.2. France Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 5.4.2.3. France Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 5.4.3. Germany 5.4.3.1. Germany Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 5.4.3.2. Germany Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 5.4.3.3. Germany Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 5.4.4. Italy 5.4.4.1. Italy Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 5.4.4.2. Italy Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 5.4.4.3. Italy Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 5.4.5. Spain 5.4.5.1. Spain Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 5.4.5.2. Spain Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 5.4.5.3. Spain Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 5.4.6. Sweden 5.4.6.1. Sweden Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 5.4.6.2. Sweden Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 5.4.6.3. Sweden Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 5.4.7. Austria 5.4.7.1. Austria Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 5.4.7.2. Austria Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 5.4.7.3. Austria Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 5.4.8.2. Rest of Europe Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 5.4.8.3. Rest of Europe Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 6. Asia Pacific Hospital Acquired Infections Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 6.2. Asia Pacific Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 6.3. Asia Pacific Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 6.4. Asia Pacific Hospital Acquired Infections Market Size and Forecast, by Country (2022-2029) 6.4.1. China 6.4.1.1. China Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 6.4.1.2. China Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 6.4.1.3. China Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 6.4.2. S Korea 6.4.2.1. S Korea Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 6.4.2.2. S Korea Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 6.4.2.3. S Korea Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 6.4.3. Japan 6.4.3.1. Japan Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 6.4.3.2. Japan Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 6.4.3.3. Japan Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 6.4.4. India 6.4.4.1. India Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 6.4.4.2. India Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 6.4.4.3. India Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 6.4.5. Australia 6.4.5.1. Australia Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 6.4.5.2. Australia Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 6.4.5.3. Australia Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 6.4.6. Indonesia 6.4.6.1. Indonesia Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 6.4.6.2. Indonesia Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 6.4.6.3. Indonesia Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 6.4.7. Malaysia 6.4.7.1. Malaysia Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 6.4.7.2. Malaysia Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 6.4.7.3. Malaysia Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 6.4.8. Vietnam 6.4.8.1. Vietnam Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 6.4.8.2. Vietnam Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 6.4.8.3. Vietnam Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 6.4.9. Taiwan 6.4.9.1. Taiwan Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 6.4.9.2. Taiwan Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 6.4.9.3. Taiwan Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 6.4.10.2. Rest of Asia Pacific Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 6.4.10.3. Rest of Asia Pacific Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 7. Middle East and Africa Hospital Acquired Infections Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 7.2. Middle East and Africa Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 7.3. Middle East and Africa Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 7.4. Middle East and Africa Hospital Acquired Infections Market Size and Forecast, by Country (2022-2029) 7.4.1. South Africa 7.4.1.1. South Africa Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 7.4.1.2. South Africa Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 7.4.1.3. South Africa Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 7.4.2. GCC 7.4.2.1. GCC Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 7.4.2.2. GCC Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 7.4.2.3. GCC Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 7.4.3. Nigeria 7.4.3.1. Nigeria Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 7.4.3.2. Nigeria Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 7.4.3.3. Nigeria Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 7.4.4.2. Rest of ME&A Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 7.4.4.3. Rest of ME&A Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 8. South America Hospital Acquired Infections Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 8.2. South America Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 8.3. South America Hospital Acquired Infections Market Size and Forecast, by Infection Type(2022-2029) 8.4. South America Hospital Acquired Infections Market Size and Forecast, by Country (2022-2029) 8.4.1. Brazil 8.4.1.1. Brazil Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 8.4.1.2. Brazil Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 8.4.1.3. Brazil Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 8.4.2. Argentina 8.4.2.1. Argentina Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 8.4.2.2. Argentina Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 8.4.2.3. Argentina Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Hospital Acquired Infections Market Size and Forecast, by Pathogen Types (2022-2029) 8.4.3.2. Rest Of South America Hospital Acquired Infections Market Size and Forecast, by Method of Treatment (2022-2029) 8.4.3.3. Rest Of South America Hospital Acquired Infections Market Size and Forecast, by Infection Type (2022-2029) 9. Global Hospital Acquired Infections Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Hospital Acquired Infections Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Becton 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Dickinson and Company (U.S.) 10.3. Steris Corporation (U.S.) 10.4. Advanced Sterilization Products 10.5. Getinge Group (Sweden) 10.6. Kimberly-Clark Corporation (U.S.) 10.7. Cantel Medical (U.S.) 10.8. BioMérieux SA (France) 10.9. Belimed AG (Switzerland) 10.10. 3M Company (U.S.) 10.11. Sterigenics International LLC. (U.S.) 10.12. Synergy Health, plc (U.K.) 10.13. Abbott 10.14. Astra Zeneca 10.15. Bayer AG 10.16. Pfizer Inc. 10.17. GlaxoSmithKline plc 10.18. Johnson and Johnson Services, Inc. 10.19. Merck and Co., Inc. 10.20. Cipla Inc. 10.21. Eli Lilly and Company 10.22. Bristol-Myers Squibb Company 10.23. F. Hoffmann-La Roche Ltd. 11. Key Findings 12. Industry Recommendations 13. Hospital Acquired Infections Market: Research Methodology 14. Terms and Glossary